SCREENING METHOD AND THERAPEUTIC AGENT FOR MENTAL DISORDER

Abstract: provided are a novel therapeutic agent for a mental disorder and a screening method for a therapeutic agent for a mental disorder. the therapeutic agent for a mental disorder includes clemastine or a pharmacologically acceptable salt thereof as an active ingredient. according to the therapeutic agent of the present invention, myelin sheath abnormality and brain dysfunction due to a mental disorder can be mitigated. further, through use of the screening method of the present invention, a therapeutic agent for a mental disorder can be screened for.

Inventor(s): Kazuo KUNISAWA, Akihiro MOURI, Toshitaka NABESHIMA

CPC Classification: G01N33/5058 (Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes ))

Search for rejections for patent application number 20250164463